Masimo
Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality
Monday, May 10, 2021 12:50PM IST (7:20AM GMT)
Researchers Found That O3 May Help Clinicians Rapidly Assess Circulatory Status in Patients Experiencing Septic Shock and Have Prognostic Value in Mortality Prediction
Masimo (NASDAQ: MASI) announced today the findings of a study published in the
Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3
® Regional Oximetry to aid in monitoring septic shock patients admitted to the ICU.
1 O3, available on the Masimo Root